-

U.S. Vaccine Tech Transfer to Africa a Win for Global Health, says AHF

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) today praised the U.S. National Institutes of Health (NIH) for committing to share innovative technologies with a South Africa-based biotech company, Afrigen, which should speed up the development and rollout of modern, highly-effective vaccines in low- and middle-income countries, including on the African continent.

“We have entered a new age of pandemics, which demands a new way of fighting infectious diseases. As we have seen so clearly with COVID-19, the ‘everyone for themselves’ approach simply does not work. That’s why the sharing of data, know-how, and technologies is essential for protecting global public health,” said AHF President Michael Weinstein. “The NIH is doing the right thing by opening up its patents to partners in developing countries – for far too long, the patent system has been used by pharma to perpetuate health inequality around the world. This may be a first small step, but it’s in the right direction.”

To date, only a quarter of the population in Africa has received at least one dose of a COVID-19 vaccine. The deficit of vaccines at the beginning of the pandemic has been attributed to wealthy countries buying up most of the supply, which has prompted calls for Africa to build up domestic production capacity and know-how. mRNA vaccines hold promise for preventing diseases beyond COVID-19, such as HIV, malaria, and tuberculosis, among others.

AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.6 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. We are currently the largest non-profit provider of HIV/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

Contacts

Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

AIDS Healthcare Foundation


Release Versions
Hashtags

Contacts

Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

More News From AIDS Healthcare Foundation

Latin America’s PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF

MEXICO CITY--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world’s largest HIV care provider, welcomes a new agreement between Gilead Sciences and the Pan American Health Organization (PAHO) that could expand access to lenacapavir for HIV prevention in 14 countries across Latin America. The agreement represents a positive step toward expanding access in the region and a victory for civil society. AHF was among the first organizations to mobilize around concerns that the initial Gilead-...

AHF to Commemorate 40 Years of Global Impact During Annual World AIDS Day Concert Celebration

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world’s largest, non-profit public health organization providing direct HIV/AIDS services to over 3.3 million clients across the globe, will celebrate 40 years of impact during its annual World AIDS Day concert commemoration. The event, which is free and open to the public, is scheduled for the evening of Monday, November 30, 2026, at the Kia Forum in Inglewood, California. RSVP to AHFWAD.org for tickets. Commemorated annually...

Sexual Health Is Health: Testing, Treatment and Prevention for All, says AHF

LOS ANGELES--(BUSINESS WIRE)--As sexually transmitted infections continue to rise worldwide, AIDS Healthcare Foundation (AHF) marks World Sexual Health Day by calling on governments and health systems to expand access to prevention, testing, and treatment services for HIV and other STIs. Despite proven tools to prevent, diagnose, and treat HIV and other STIs, gaps in access continue to put millions of people at risk globally. With an estimated 1.2 million new HIV infections each year globally,...
Back to Newsroom